- Report
- June 2024
- 200 Pages
Global
From €7175EUR$7,950USD£6,221GBP
- Report
- February 2024
- 179 Pages
Global
From €2708EUR$3,000USD£2,347GBP
- Report
- September 2023
- 115 Pages
Global
From €4061EUR$4,500USD£3,521GBP
- Report
- July 2023
- 119 Pages
Global
From €4061EUR$4,500USD£3,521GBP
- Report
- June 2024
- 140 Pages
Latin America
From €3492EUR$3,869USD£3,027GBP
- Report
- February 2025
- 233 Pages
Global
From €2256EUR$2,500USD£1,956GBP
- Report
- January 2025
- 199 Pages
Global
From €2256EUR$2,500USD£1,956GBP
- Report
- June 2025
- 400 Pages
Global
From €4467EUR$4,949USD£3,872GBP
- Report
- June 2025
- 250 Pages
India
From €2517EUR$2,789USD£2,182GBP
- Report
- June 2025
- 400 Pages
Global
From €4467EUR$4,949USD£3,872GBP
- Report
- June 2025
- 400 Pages
Global
From €4467EUR$4,949USD£3,872GBP
- Report
- August 2024
- 200 Pages
Global
From €4467EUR$4,949USD£3,872GBP
- Report
- June 2023
- 140 Pages
Global
From €4467EUR$4,949USD£3,872GBP
- Report
- April 2023
- 160 Pages
Global
From €4467EUR$4,949USD£3,872GBP
- Report
- April 2025
- 142 Pages
North America
From €3114EUR$3,450USD£2,700GBP
- Report
- April 2025
- 137 Pages
From €3114EUR$3,450USD£2,700GBP
- Report
- April 2025
- 163 Pages
Europe
From €3114EUR$3,450USD£2,700GBP
- Report
- April 2025
- 161 Pages
Asia Pacific
From €3114EUR$3,450USD£2,700GBP
- Report
- October 2024
- 139 Pages
Middle East, Africa
From €3114EUR$3,450USD£2,700GBP
- Report
- July 2024
- 108 Pages
Middle East, Africa
From €3114EUR$3,450USD£2,700GBP

T Cell Therapies are a type of biotechnology that involves the use of a patient's own T cells to treat diseases. T cells are a type of white blood cell that play a key role in the body's immune system. T Cell Therapies involve the extraction of T cells from a patient, engineering them to recognize and attack specific targets, and then reintroducing them into the patient's body. This type of therapy has been used to treat a variety of cancers, including leukemia, lymphoma, and multiple myeloma. It has also been used to treat autoimmune diseases, such as rheumatoid arthritis and Crohn's disease.
T Cell Therapies are a rapidly growing field of biotechnology, with many companies investing in research and development. Companies such as Kite Pharma, Juno Therapeutics, and Novartis are leading the way in developing and commercializing T Cell Therapies. Other companies, such as Gilead Sciences, Celgene, and Regeneron, are also investing in the field. Show Less Read more